Add Company
Join Now

Kojin Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kojin Therapeutics's estimated annual revenue is currently $3.7M per year.(i)
  • Kojin Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Kojin Therapeutics has 24 Employees.(i)
  • Kojin Therapeutics grew their employee count by -8% last year.

Kojin Therapeutics's People

NameTitleEmail/Phone
1
CEO, Gallop OncologyReveal Email/Phone
2
Chairman, President, & CEOReveal Email/Phone
3
SVP and Chief Scientific OfficerReveal Email/Phone
4
Co-FounderReveal Email/Phone
5
SVP, Drug DiscoveryReveal Email/Phone
6
Associate DirectorReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Sr. Executive AssistantReveal Email/Phone
9
ConsultantReveal Email/Phone
10
Founding ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Kojin Therapeutics?

We translate our deep biological insight into cell states to small-molecule therapeutics. Our approach provides novel ways of treating cancer, fibrosis, ischemia and immune modulation. Kojin Therapeutics is founded by Benjamin Cravatt, Stephanie Dougan, Stuart Schreiber and Vasanthi Viswanathan.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M24-4%N/A
#2
$3.5M24-14%N/A
#3
$5.1M24-38%N/A
#4
$2.4M24N/AN/A
#5
$2.4M24N/AN/A